Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 3
1998 1
1999 2
2001 1
2002 3
2003 1
2004 2
2006 1
2007 2
2008 1
2009 2
2010 3
2011 1
2013 1
2015 2
2016 3
2017 1
2018 3
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.
González-Martín A, Alba E, Ciruelos E, Cortés J, Llombart A, Lluch A, Andrés R, Álvarez I, Aramendía JM, de la Peña FA, Barnadas A, Batista N, Calvo L, Galve E, García-Palomo A, García-Sáenz JÁ, de la Haba J, López R, López-Vivanco G, Martínez-Jáñez N, de Dueñas EM, Plazaola A, Rodríguez-Lescure Á, Ruiz M, Sánchez-Rovira P, Santaballa A, Seguí MÁ, Tusquets I, Zamora P, Martín M. González-Martín A, et al. Among authors: aramendia jm. Curr Cancer Drug Targets. 2016;16(5):415-28. doi: 10.2174/1568009615666150817121731. Curr Cancer Drug Targets. 2016. PMID: 26278712 Review.
[Anesthesia for the patient with cancer].
Monedero P, Calderón R, Moreno-Jiménez M, Aramendía JM, Otero M. Monedero P, et al. Among authors: aramendia jm. Rev Esp Anestesiol Reanim. 2001 Nov;48(9):423-33. Rev Esp Anestesiol Reanim. 2001. PMID: 11792286 Review. Spanish.
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy.
de la Fuente A, Santisteban M, Lupón J, Aramendía JM, Díaz A, Santaballa A, Hernándiz A, Sepúlveda P, Cediel G, López B, Picazo JML, Mazo MM, Rábago G, Gavira JJ, García-Bolao I, Díez J, González A, Bayés-Genís A, Ravassa S. de la Fuente A, et al. Among authors: aramendia jm. Cancers (Basel). 2022 Jun 14;14(12):2941. doi: 10.3390/cancers14122941. Cancers (Basel). 2022. PMID: 35740602 Free PMC article.
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes.
Salas-Benito D, Conde E, Tamayo-Uria I, Mancheño U, Elizalde E, Garcia-Ros D, Aramendia JM, Muruzabal JC, Alcaide J, Guillen-Grima F, Minguez JA, Amores-Tirado J, Gonzalez-Martin A, Sarobe P, Lasarte JJ, Ponz-Sarvise M, De Andrea CE, Hervas-Stubbs S. Salas-Benito D, et al. Among authors: aramendia jm. Br J Cancer. 2021 Mar;124(6):1138-1149. doi: 10.1038/s41416-020-01218-4. Epub 2021 Jan 5. Br J Cancer. 2021. PMID: 33402737 Free PMC article.
Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis.
Jablonska PA, Cambeiro M, Gimeno M, Aramendía JM, Mínguez JA, Alcázar JL, Aristu JJ, Calvo FA, Martínez-Monge R. Jablonska PA, et al. Among authors: aramendia jm. Clin Transl Oncol. 2021 Sep;23(9):1934-1941. doi: 10.1007/s12094-021-02601-0. Epub 2021 Apr 9. Clin Transl Oncol. 2021. PMID: 33835408
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial.
Martínez-Monge R, Valtueña Peydró G, Cambeiro M, Aramendía JM, Gimeno M, Santisteban M, Lecanda F, Minguez JA, Alcázar JL, Jurado M. Martínez-Monge R, et al. Among authors: aramendia jm. Brachytherapy. 2018 Sep-Oct;17(5):734-741. doi: 10.1016/j.brachy.2018.04.007. Epub 2018 May 24. Brachytherapy. 2018. PMID: 29803537 Clinical Trial.
An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial).
Chiva L, Ordás P, Martin-Calvo N, Aramendia JM, Sanchez Lorenzo L, Gallego Martínez A, Vizcay Á, Minguez JA, Manzour N, Vázquez-Vicente D, Chacon E, Castellanos T, Gonzalez Martin A. Chiva L, et al. Among authors: aramendia jm. Int J Gynecol Cancer. 2024 Mar 13:ijgc-2024-005354. doi: 10.1136/ijgc-2024-005354. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38479803
38 results